Showing results (1-10 of 364) with videos related to
Sort By:
Pageof 37
Drugs|November 20, 2008
Mild to moderate Crohn's disease: an evidence-based treatment algorithmKaren Wong, Brian BresslerTherapeutic Advances in Gastroenterology|April 14, 2023
Is there an optimal sequence of biologic therapies for inflammatory bowel disease?Brian BresslerCanadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 2, 2010
Mycobacterium avium paratuberculosis and the etiology of Crohn's disease: a review of the controversy from the clinician's perspectiveGreg Rosenfeld, Brian BresslerThe American Journal of Gastroenterology|September 7, 2012
The truth about cigarette smoking and the risk of inflammatory bowel diseaseGreg Rosenfeld, Brian BresslerImmunotherapy|October 24, 2014
Vedolizumab for ulcerative colitis and Crohn's disease: results and implications of GEMINI studiesMindy Cw Lam, Brian BresslerExpert Review of Gastroenterology & Hepatology|December 17, 2008
Natalizumab: pharmacology, clinical efficacy and safety in the treatment of patients with Crohn's diseaseHin Hin Ko, Brian BresslerDigestive Diseases and Sciences|May 17, 2019
Acute Severe Ulcerative Colitis: The Oxford Criteria No Longer Predict In-Hospital Colectomy RatesAlice C Moore, Brian BresslerExpert Opinion on Biological Therapy|November 17, 2015
Vedolizumab for the treatment of ulcerative colitisNeal Shahidi, Brian Bressler, Remo PanaccioneCritical Reviews in Food Science and Nutrition|January 9, 2015
The Impact of Dietary Interventions on the Symptoms of Inflammatory Bowel Disease: A Systematic ReviewAshley Charlebois, Greg Rosenfeld, Brian BresslerJournal of Crohn'S & Colitis|March 8, 2013
The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: a systematic review and meta-analysisGreg Rosenfeld, Hong Qian, Brian BresslerPageof 37